Emergent Biosolutions (EBS) Institutional Ownership

78.40% of Emergent Biosolutions' stock is owned by institutional investors. Learn more on EBS's institutional investor holdings.

Of the 154 institutional investors that purchased Emergent Biosolutions' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: State Street Corp ($1.96M), Millennium Management LLC ($1.90M), Dimensional Fund Advisors LP ($1.35M), American Century Companies Inc. ($1.28M), Oak Hill Advisors LP ($1.11M), Jain Global LLC ($942.69K), and Acadian Asset Management LLC ($852.10K).

Institutional investors have bought a total of 8,348,264 shares in the last 24 months. This purchase volume represents approximately $78.08M in transactions.

Of the 55 institutional investors that sold Emergent Biosolutions' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Qube Research & Technologies Ltd ($920.29K), Millennium Management LLC ($677.61K), Invesco Ltd. ($541.96K), Assenagon Asset Management S.A. ($490.46K), Marshall Wace LLP ($414.41K), Jump Financial LLC ($271.86K), and Trexquant Investment LP ($224.60K).

Institutional investors have sold a total of 5,334,048 shares in the last 24 months. This volume of shares sold represents approximately $48.08M in transactions.